Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J AND DBA/2J)
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 28 (2) , 117-122
- https://doi.org/10.1016/0028-3908(89)90046-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dissociated effects of inhibitors of enkephalin-metabolising peptidase or naloxone on various nociceptive responsesEuropean Journal of Pharmacology, 1986
- Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranesBiochemistry, 1985
- Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitorsEuropean Journal of Pharmacology, 1983
- Participation of both ‘enkephalinase’ and aminopeptidase activities in the metabolism of endogenous enkephalinsNeuroscience, 1983
- Pain control by endogenous enkephalins is mediated by MU opioid receptorsLife Sciences, 1983
- Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptorsPsychiatry Research, 1982
- Strain dependent effects of the enkephalin analogue FK 33-824 on locomotor activity in micePharmacology Biochemistry and Behavior, 1981
- Regional acetylcholine turnover rates in the brains of three inbred strains of mice: Correlation with some interstrain behavioural differencesBrain Research, 1977
- Correlation of Behavioural Differences in Three Strains of Mice with Differences in Brain AminesNature, 1974
- Facilitation de réactions nociceptives par la naloxone chez la souris et chez le ratPsychopharmacology, 1974